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Release of catecholamines from bovine adrenal chromafhn cells exposed to mastoparan, a wasp venom peptide which 
activates GTP-binding proteins and phospholipase 4, was evaluated. Release of catecholamines was dependent on mas- 
toparan concentration and time of exposure. This release was, however, independent of extracellular calcium and accom- 
panied by release of the cytoplasmic marker lactate dehydrogenase. Mastoparan also inhibited catecholamine secretion 
evoked by nicotine, but the peptide had little or no effect on release induced by other secretagogues. These findings suggest 
that in chromaffin cells mastoparan is not a secretagogue but rather causes cell lysis and blocks nicotinic receptor func- 
tion. 
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1. INTRODUCTION 
Mastoparan, a tetradecapeptide from wasp 
venom (Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu- 
Ala-Lys-Lys-Be-LeuNHz), is reportedly a secreta- 
gogue for a variety of cell types including peri- 
toneal mast cells [ 1,2], anterior pituitary cells [3], 
and adrenal chromaffin cells [4]. The activities of 
mastoparan and structurally related peptides ap- 
parently result from activation of GTP-binding 
proteins (G-proteins) and subsequent stimulation 
of phosphoinositide-specific phospholipase C or 
from direct stimulation of phospholipase A2 
[2,5,6]. In mast cells, activation of a pertussis 
toxin-sensitive G-protein mediates mastoparan- 
induced histamine release [6]. 
Recent studies have indicated a role for G- 
proteins in exocytotic secretion from adrenal 
medullary chromaffin cells. Nonhydrolyzable 
guanine nucleotide analogs stimulate calcium- 
independent catecholamine secretion from perme- 
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abilized chromaffin cells [7,8]. Pertussis toxin, 
which ADP ribosylates the a-subunit of several G- 
proteins, potentiates catecholamine secretion from 
chromaffin cells [9, lo] and itself stimulates a slow 
catecholamine release [ 111. Because of the poten- 
tial for elucidating the molecular mechanisms of 
exocytosis including the role of G-proteins, the 
present study was undertaken to examine in detail 
the effects of mastoparan on secretion from 
chromaffin cells. The results show that the chro- 
maffin cell ‘secretion’ observed does not result 
from exocytosis, but rather from lysis of the cells. 
2. MATERIALS AND METHODS 
2.1. Materials 
Mastoparan was obtained from Bachem, Inc. (Torrance, 
CA). Pertussis toxin, atropine, hexamethonium, veratridine, 
tetrodotoxin, pertussis toxin, and nicotine were obtained from 
Sigma Chemical (St. Louis, MO). Ionomycin and d- 
tubocurarine were obtained from Calbiochem (San Diego, CA). 
2.2. Cell cultures 
Bovine adrenal chromaffin cells were isolated by collagenase 
digestion and density gradient centrifugation on Renografin 
[ 121. The cells were further purified by differential plating [ 131, 
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and finally plated in serum-containing medium at a density of 
400000-500000 per cm’ in 24-well tissue culture plates (Corn- 
ing). After approx. 16 h, the serum-containing medium was 
removed and culture continued in serum-free medium [14]. 
Cultures were used between 2 and 10 days after plating. 
2.3. Catecholamine release and analysis 
Culture medium was removed and replaced with release 
medium (150 mM NaCl, 5 mM KCI, 2 mM CaCl2, 7.8 mM 
glucose, and 5 mM Hepes, pH 7.4) at 37°C with or without 
mastoparan or other additions. At the indicated times, aliquots 
of the medium were removed and acidified (0.1 M perchloric 
acid final concentration). After removal of release medium, 
cells were lysed by addition of cold 0.1 M perchloric acid. 
Norepinephrine, epinephrine, and dopamine were measured by 
reversed-phase high-performance liquid chromatography with 
electrochemical detection [12]. Because only minor differences 
in the secretion of the different catecholamines were observed, 
results are reported as the percentage of total cell 
catecholamines released. The catecholamine contents of the 
cultures averaged 140 nmol per lo6 cells. 
2.4. Lactate dehydrogenase r lease and assay 
Cultures were incubated at 37°C in release medium with or 
without mastoparan. Aliquots of the medium were removed as 
indicated. Release medium and cell lysates (0.2% Triton X-100 
in release medium) were kept on ice and assayed within 4 h. 
Lactate dehydrogenase activity was measured as described [15]. 
The lactate dehydrogenase activity of the cultures averaged 
31 nmol per min per lo6 cells. 
3. RESULTS AND DISCUSSION 
3.1. Catecholamine r lease from mastoparan- 
stimulated chromaffin cells 
As reported [4], mastoparan induced release of 
catecholamines from cultures of bovine adrenal 
medullary chromaffin cells. Catecholamine release 
was dependent on the concentration of masto- 
paran (fig.1) and on the time of exposure to the 
peptide (fig.2). Mastoparan-induced catechol- 
amine release was not blocked by cholinergic anta- 
gonists (1 PM atropine, 50 PM d-tubocurarine, 
500 /IM hexamethonium) or by the sodium channel 
blocker tetrodotoxin (1 PM). Catecholamine 
release elicited by exposure to mastoparan was 
unaffected by pretreatment (20 h) of the cultures 
with pertussis toxin (10 to 1000 ng/ml), conditions 
which enhanced nicotinic secretion by approx. 
35070, as reported [13-151. 
3.2. Lactate dehydrogenase release from 
mastoparan-treated c lls 
Further studies, however, revealed that 
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Fig. 1. Concentration dependence of mastoparan on release of 
catecholamines from chromaffin cells. Incubation time was 
15 min. Data are the means of 3 determinations, except for the 
100 pM concentration where n = 1; the standard errors of the 
mean are smaller than the plotting symbols used. 
mastoparan-induced catecholamine release was in- 
dependent of extracellular calcium and that the 
cytoplasmic marker lactate dehydrogenase was 
released during exposure to the peptide (table 1). 
These results suggest that mastoparan is either 
directly lysing the cells or exerts a lytic effect by ac- 
tivation of phospholipase AZ as reported for 
several cell types [2]. Alternatively, activation of 
G-proteins [5], leading to stimulation of other 
phospholipases, could account for these results. 
Preferential release of lactate dehydrogenase may 
indicate permeabilization of cells without escape of 
chromaffin vesicles, as seen with digitonin [15], 
although this was not observed consistently. 
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Fig.2. Time course for mastoparan-induced catecholamine 
release. Data represent the averages of duplicate determi- 
nations. 
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Table 1 
Calcium dependence of lactate dehydrogenase and catecholamine release induced by 
mastoparan 
April 1989 
Addition Lactate dehydrogenase Catecholamine 
Calcium EGTA Calcium EGTA 
None 6.0 f 0.2 7.1 * 0.5 2.1 f 0.1 7.3 f 0.4 
Mastovaran. 30 uM 34.9 f 0.7= 51.5 f 0.8” 21.1 f 0.58*b 26.2 + l.5a*c 
a p < 0.001 compared to no mastoparan added 
b p < 0.05 compared to lactate dehydrogenase r lease under the identical condition 
’ p < 0.001 compared to lactate dehydrogenase r lease under the identical condition 
Chromaffin cell cultures were incubated for 10 min either in release medium 
containing 2.0 mM calcium or calcium-free medium containing 0.5 mM EGTA. Data 
are presented as mean + SE, n = 3 
3.3. Effects of mastoparan on catecholamine 
secretion evoked by other agents 
The effects of low concentrations of mastoparan 
on catecholamine release evoked by other secreta- 
gogues were also examined (table 2). Mastoparan 
inhibited secretion induced by nicotine (table 2) 
and acetylcholine (not shown), but had little or no 
effect on secretion resulting from the other agents 
tested. Hence, low concentrations of mastoparan 
which produce little or no lysis of chromaffin cells 
do not synergistically activate release of 
catecholamines in the presence of secretagogues. 
Neither does mastoparan block the secretory 
mechanism, except by interaction with the 
nicotinic acetylcholine receptor. 
Table 2 
Effect of mastoparan on secretion induced by other agents 
Secretagogue Catecholamine release (vo) 
- mastoparan + mastoparan 
None 4.2 + 0.6 4.8 + 0.2 
Nicotine, 10 PM 17.7 + 0.3 8.1 + 0.2” 
Veratridine, 40 PM 26.8 r 0.4 24.9 f 0.2b 
Barium chloride, 250 FM 24.0 r 0.8 24.7 rt 0.6 
Potassium, 50 mM 13.7 f 0.2 14.0 f 0.02 
Ionomycin, 20 pM 37.8 f 0.5 37.2 f 1.7 
a p c 0.001 compared to cultures without mastoparan addition 
b p < 0.05 compared to cultures without mastoparan addition 
Chromaffin cells were incubated (15 min) as indicated * 5 /rM 
mastoparan. KC1 was substituted for NaCl to achieve 50 mM 
K+. Data are presented as mean * SE, n = 3 
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